Virtually no eclosed adults emerge upon expression of AdoRScer\UAS.cDa under the control of Scer\GAL4Act5C.Switch.PR. Microinjection of the adenosine receptor antagonist SCH58261 into third instar larvae can partially rescue the lethality and leads to the emergence of approximately 20% of the animals as adults.
Expression of AdoRScer\UAS.cDa under the control of Scer\GAL4Act5C.PP results in lethality during the transition from the first to second larval instar.
Expression of AdoRScer\UAS.cDa under the control of Scer\GAL4sev.PJ or Scer\GAL4pros.PJ results in late pupal lethality. The pharate adults survive for several hours when removed from the pupal case at the normal eclosion time, but are unable to move or spread their wings.
Expression of AdoRScer\UAS.cDa under the control of Scer\GAL4en-e16E results in flies with folded and blistered wings (100%) and melanotic tumours in the head capsule (80%).
Expression of AdoRScer\UAS.cDa under the control of Scer\GAL430A results in flies with folded and blistered wings (100%) and melanotic tumours in the head capsule (50%).
Expression of AdoRScer\UAS.cDa under the control of Scer\GAL4pnr-MD237 results in flies with a reduced scutellum and cross post-scutellar bristles. Flies expressing two copies of AdoRScer\UAS.cDa under the control of Scer\GAL4pnr-MD237 emerge very rarely (less than 5%), have a strong cleft in the thorax and complete loss of the scutellum and have defects in the melanization of abdominal cuticle.
AdoRUAS.cDa, GαsUAS.cCa, Scer\GAL4en-e16E has visible phenotype
AdoRUAS.cDa, GαsUAS.cCa, Scer\GAL4en-e16E has lethal | pharate adult stage phenotype
AdoRUAS.cDa, GαsUAS.cCa, Scer\GAL4en-e16E has wing phenotype
Animals co-expressing G-sα60AScer\UAS.cCa and AdoRScer\UAS.cDa under the control of Scer\GAL4en-e16E show 20% lethality as pharate adults, whereas expression of either G-sα60AScer\UAS.cCa or AdoRScer\UAS.cDa alone under the control of Scer\GAL4en-e16E does not cause lethality. The flies that do emerge show strong wing deformation and melanisation.